Jim Cramer likes the 10 early-stage drugs J&J has in its pipeline, among other reasons.
Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.
Jim Cramer reveals why his Action Alerts PLUS charitable trust portfolio is initiating coverage of Johnson & Johnson (JNJ) on Tuesday.
Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.
Growth catalysts prompt bigger position in hotel chain.
The social media aggregation app could be a fit, but we'd be disappointed in an all-equity deal at current levels.
We'll add Johnson & Johnson to the portfolio and close our position in Merck.
A Justice Department fine seems to be priced in.
What investors should look for when Workday, the enterprise cloud app provider, reports first-quarter results after the closing bell on Tuesday.
Workday (WDAY), the enterprise cloud app provider, is slated to report its first quarter results after the closing bell on Tuesday.